Covid-19: Menarini Group Converts Production Plant to Produce and Donate Disinfectant Gel

Food and Healthcare Press Releases Tuesday March 17, 2020 12:54
FLORENCE Italy--17 Mar--PRNewswire/InfoQuest
United in the fight against Covid-19. In a difficult time for Italy and the entire world, pharmaceutical company Menarini Group is taking healthcare professionals and patient health even more to heart.

The Board of Directors of Menarini, chaired by Eric Cornut, has decided to convert part of its production plant in Florence (Italy) to manufacturing disinfectant gel to be donated to those hospitals and healthcare organisations who are in the front line in the battle against Coronavirus.

Menarini will be producing 5 tons of disinfectant gel per week which will be distributed throughout the Italian territory and free of charge by Italy's national Civil Protection Department.

"Doctors and healthcare professionals are the true 'heroes' in the fight against COVID-19 and through our donation of disinfectant gel we hope to be able to help them work in greater safety," stated Elcin Barker Ergun, Chief Executive Officer Menarini Group.

The Menarini Group

The Menarini Pharmaceutical Group, with headquarters in Florence, is present in more than 130 countries worldwide, with EUR 3,667 million in turnover and more than 17.000 employees. With 7 centres for Research & Development, Menarini products are present in the most important treatment areas, including cardiovascular, pulmonology, infectious diseases, diabetes, gastroenterology and anti-inflammatory/analgesic products. Pharmaceutical production is carried out in the Group's 16 manufacturing plants located in Italy and abroad, which produce and distribute over 585 million packets of product a year. Menarini's pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients throughout the world.

Logo - https://mma.prnewswire.com/media/1134482/MENARINI_GROUP_Logo.jpg

Latest Press Release

Caviarlieri: The World's Only Caviar Food Supplement with the Latest Innovation in Swiss Cellular Therapy Technology

Encapsulating the potent bioactive nutrients of Caviar into a supplement has been a dream and a formidable challenge for the Anti-Aging Medical World for several decades. Caviarlieri Limited, through its global panel of Anti-Aging medical experts has...

Coping With the Coronavirus, Rambam Healthcare Campus in Israel Joins Forces With Elbit Systems to Deploy a Management & Control Technology

The Rambam Healthcare Campus ("Rambam") in Haifa, Israel starts operating EX-TEAMS, a cellular based management and control system that was jointly developed with Elbit Systems. EX-TEAMS is based on an Elbit Systems' Command & Control (C2) technology...

Ansell Urges Global Priority For Supply Of Personal Protective Equipment

Ansell Limited, a global leader in protective solutions, is working with governments and health organizations worldwide to ensure unrestricted personal protective equipment (PPE) manufacture and supply is given top priority during the COVID-19...

Yiling Pharmacy Lianhua Qingwen has been approved by the Thai FDA

On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the Food and Drug Administration of Thailand. Lianhua Qingwen Capsule is recognized as in...

EW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions

Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as...

Related Topics